The presence of functional thromboxane A 2 receptors in neonatal rat oligodendrocytes and human oligodendroglioma cells was investigated using immunocytochemistry, ligand affinity chromatography, radioligand binding analysis, immunoblot analysis, and calcium mobilization studies. Immunocytochemical studies revealed the presence of receptor protein on both oligodendrocytes and human oligodendroglioma cells. Ligand affinity chromatography allowed for the purification of a protein with an electrophoretic mobility (55 kDa) indistinguishable from human platelet thromboxane A 2 receptors. This affinity purified protein was immunoreactive against a polyclonal anti-thromboxane A 2 receptor antibody. Intact human oligodendroglioma cells specifically bound Thromboxane A 2 (TXA 2 ) 1 is a bioactive arachidonic acid metabolite with thrombotic, vasospastic, and bronchospastic properties (1-3). It has been implicated in a variety of physiological and pathophysiological states (4). The receptor for TXA 2 has been purified (5, 6), cloned, and sequenced, and the structure of the gene indicates that this receptor is a member of the seven transmembrane domain, G-protein-coupled receptor superfamily. The receptor protein has been located in a variety of tissues including blood platelets (7), vascular smooth muscle (8, 9), vascular endothelium (10), placenta (11), and kidney (12) and appears to be directly involved in the regulation of intracellular calcium levels (13). In this regard, previous studies have provided evidence that the TXA 2 receptor protein is coupled to at least one G-protein, i.e. G q in platelets (14, 15) and astrocytes (16), and appears to modulate phospholipase C- activity resulting in activation of the inositol triphosphate second messenger system (17, 18).Although highly specific agonists and antagonists have proven to be of significant value in characterizing TXA 2 receptors in a number of different cell lines, little information is currently available concerning their existence or function in the central nervous system. To a large extent, this has been due to the presence of high lipid concentrations in central nervous system tissue. Thus, nonspecific binding has obscured the demonstration of receptor binding in solubilized brain, due to the lipophilic nature of TXA 2 receptor ligands. In addition, the heterogeneity of cell types in the central nervous system has complicated attempts at receptor localization at a cellular level.Based on these limitations, previous studies have employed cultured cell systems in an effort to investigate the presence of TXA 2 receptors in the central nervous system. In these experiments, it was demonstrated that cultured rabbit astrocytes were capable of specifically binding the TXA 2 ligand ONO . These results, therefore, provided evidence that at least one cellular component of the central nervous system possesses TXA 2 receptor activity. However, since astrocytes are ubiquitously distributed in the brain, it has not been possible to ascribe a specific or unique function for...